Ranbaxy rises despite reporting Q3 consolidated net loss of Rs 454.17 crore

30 Oct 2013 Evaluate

Ranbaxy Laboratories is currently trading at Rs. 387.90, up by 2.25 points or 0.58% from its previous closing of Rs. 385.65 on the BSE.

The scrip opened at Rs. 364.50 and has touched a high and low of Rs. 389.00 and Rs. 363.90 respectively. So far 644643 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 559.80 on 08-Nov-2012 and a 52 week low of Rs. 253.95 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 404.90 and Rs. 381.50 respectively. The current market cap of the company is Rs. 15747.22 crore.

The promoters holding in the company stood at 63.51% while Institutions and Non-Institutions held 19.46% and 14.29% respectively.

Ranbaxy Laboratories has reported results for the third quarter ended September 30, 2013.

The company has reported a net loss Rs 842.23 crore as compared to a net profit of Rs 552.19 crore in the same quarter previous year. Total income of the company has decreased by 3.74% at Rs 1470.18 crore for quarter under review as compared to Rs 1527.36 crore for the quarter ended September 30, 2012.

On the consolidated basis, the group has reported a net loss after taxes, minority Interest and share of proflt/(loss) of associates at Rs 454.17 crore as compared to a net profit of Rs 754.17 crore in the same quarter previous year. However, total income of the group rose 1.93% to Rs 2827.73 crore for quarter under review as against Rs 2774.23 crore in corresponding quarter previous year.

 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×